← Mechanisms of action
CD80
SINGLE PROTEINHomo sapiens
Preferred name: T-lymphocyte activation antigen CD80 ChEMBL ↗
Linked proteins
Drugs acting on this target (14)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| cd80 breast cancer vaccine | Immunity, active | experimental | Vaccine | CD80 immunity, active |
| hbm1020 | Immunity, active | experimental | mAb | CD80 immunity, active |
| recombinant fowlpox-b7.1 vaccine | Immunity, active | experimental | Vaccine | CD80 immunity, active |
| rv-b7.1 | Immunity, active | experimental | Vaccine | CD80 immunity, active |
| vaccinia-b7.1 vaccine | Immunity, active | experimental | Vaccine | CD80 immunity, active |
| abatacept (orencia) | Inhibitor | approved | Recombinant protein | CD80 inhibitor |
| belatacept (nujolix) | Inhibitor | approved | Recombinant protein | CD80 inhibitor |
| fpt155 | Inhibitor | experimental | Recombinant protein | CD80 inhibitor |
| galiximab | Inhibitor | experimental | mAb | CD80 inhibitor |
| km602 | Inhibitor | experimental | Recombinant protein | CD80 inhibitor |
| rhudex | Inhibitor | experimental | Small molecule | CD80 inhibitor |
| gi-102 | Modulator | experimental | Recombinant protein | CD80 modulator |
| Prezalumab | Supplementation | experimental | mAb | CD80 supplementation |
| rhigm12b7 | Supplementation | experimental | mAb | CD80 supplementation |